Alpa Bavishi

Alpa Bavishi is a QA Specialist at CTMC, a joint venture between Resilience and MD Anderson Cancer Center, since May 2022. Prior to this role, Alpa served as a Quality Assurance Associate at Agnitioinc from July 2018 to June 2022 and briefly worked as a Quality Assurance and Regulatory Affairs Specialist at Globiox in February 2022. Alpa also held the position of Quality Assurance designee at Novitium Pharma LLC from December 2016 to June 2018. Currently pursuing a Master’s Degree in Pharmacy Administration and Regulatory Affairs at St. John's University, Alpa has accumulated diverse experience in quality assurance and regulatory compliance within the pharmaceutical sector.